TATEISHI Kazunari
School of Medicine Department of Medicine
Senior Assistant Professor
Researcher Information
Research activity information
Paper
- Nonfibrotic Hypersensitivity Pneumonitis Complicated by Chronic Progressive Pulmonary Aspergillosis : A Case Report
Kanayama, Risa; Wada, Yosuke; Tateishi, Kazunari; Kitaguchi, Yoshiaki; Ushiki, Atsuhito; Hanaoka, Masayuki
The Shinshu Medical Journal, 71(4), 235-240, Aug. 2023
- Rechallenge of afatinib for EGFR-mutated non-small cell lung cancer previously treated with osimertinib: a multicenter phase II trial protocol (REAL study)
Araki T, Kanda S, Komatsu M, Sonehara K, Tateishi K, Takada M, Kato A, Yamamoto M, Nishie K, Hama M, Agatsuma T, Kakizaki Y, Yoshiike F, Matsuo A, Chiaki T, Samizo K, Takagi Y, Yamaura M, Hanaoka M, Koizumi T.
Transl Lung Cancer Res, 2023 - Predictive Factors Associated with Long-Term Response to Combination Immunotherapy in Patients with Untreated Advanced Non-Small-Cell Lung Cancer: A Multicenter Retrospective Study
Sonehara K, Ozawa R, Hama M, Nozawa S, Agatsuma T, Nishie K, Kato A, Matsuo A, Araki T, Komatsu M, Tateishi K, Hanaoka M.
ONCOLOGY, 2023 - C-PLAN index as a prognostic factor for patients with previously untreated advanced non-small cell lung cancer who received combination immunotherapy: A multicenter retrospective study
Sonehara K, Ozawa R, Hama M, Nozawa S, Agatsuma T, Nishie K, Kato A, Matsuo A, Araki T, Komatsu M, Tateishi K, Hanaoka M.
Thorac Cancer, 2023 - Usual Interstitial Pneumonia Pattern Interstitial Lung Disease Developed in a Patient with IgG4-related Chronic Sclerosing Sialadenitis
Yamamoto H, Komatsu M, Sonehara K, Ikuyama Y, Urushihata K, Tateishi K, Kitaguchi Y, Ushuiki A, Asaka S, Uehara T, Kawakami S, Mori K, Hamanaka K, Nishie K, Hebisawa A, Hanaoka M.
Intern Med, 2022 - Prospective assessment using (18)F-FDG PET/CT as a novel predictor for early response to PD-1 blockade in non-small-cell lung cancer
Yamaguchi O, Kaira K, Naruse I, Umeda Y, Honda T, Watanabe S, Ichikawa K, Tateishi K, Kasahara N, Higuchi T, Hashimoto K, Shinomiya S, Miura Y, Shiono A, Mouri A, Imai H, Iizuka K, Ishizuka T, Minato K, Suda S, Kagamu H, Mori K, Kuji I, Seki N.
Sci Rep, 2022 - Current status of first-line treatment with pembrolizumab for non-small-cell lung cancer with high PD-L1 expression
Ikezawa Y, Mizugaki H, Morita R, Tateishi K, Yokoo K, Sumi T, Kikuchi H, Kitamura Y, Nakamura A, Kobayashi M, Aso M, Kimura N, Yoshiike F, Furuta M, Tanaka H, Sekikawa M, Hachiya T, Nakamura K, Shimokawa M, Oizumi S.
Cancer Sci, 2022 - Association of lung immune prognostic index with survival outcome in advanced thymic carcinoma patients treated with palliative intent chemotherapy
Araki T, Tateishi K, Komatsu M, Sonehara K, Kanda S, Hanaoka M, Koizumi T.
Thorac Cancer, 2022 - Predictive value of post-treatment C-reactive protein-to-albumin ratio in locally advanced non-small cell lung cancer patients receiving durvalumab after chemoradiotherapy
Araki T, Tateishi K, Komatsu M, Sonehara K, Wasamoto S, Koyama S, Yoshiike F, Hama M, Nishie K, Kondo D, Agatsuma T, Kato A, Takata M, Kanda S, Hanaoka M, Koizumi T.
Thorac Cancer, 2022 - Predictive Factors Correlated with the Development of Immune-Related Adverse Events in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors
Sonehara K, Tateishi K, Araki T, Komatsu M, Akahane J, Yamamoto H, Hanaoka M.
Cancer Manag Res, 2022 - Prognostic value of the geriatric nutritional risk index among patients with previously treated advanced non-small cell lung cancer who subsequently underwent immunotherapy
Sonehara, Kei; Tateishi, Kazunari; Araki, Taisuke; Komatsu, Masamichi; Yamamoto, Hiroshi; Hanaoka, Masayuki;
Thoracic cancer, 12(9), 1366-1372, May 2021 - The Role of Immune-Related Adverse Events in Prognosis and Efficacy Prediction for Patients with Non-Small Cell Lung Cancer Treated with Immunotherapy: A Retrospective Clinical Analysis
Sonehara, Kei; Tateishi, Kazunari; Araki, Taisuke; Komatsu, Masamichi; Yamamoto, Hiroshi; Koizumi, Tomonobu; Hanaoka, Masayuki;
ONCOLOGY, 99(5), 271-279, Apr. 2021 - Clinical utility of the C-reactive protein:albumin ratio in non-small cell lung cancer patients treated with nivolumab
Araki, Taisuke; Tateishi, Kazunari; Sonehara, Kei; Hirota, Shuko; Komatsu, Masamichi; Yamamoto, Manabu; Kanda, Shintaro; Kuraishi, Hiroshi; Hanaoka, Masayuki; Koizumi, Tomonobu;
Thoracic cancer, 12(5), 603-612, Mar. 2021 - Prognostic implication of erector spinae muscles in non-small-cell lung cancer patients treated with immuno-oncology combinatorial chemotherapy
Araki T, Kitaguchi Y, Suzuki Y, Komatsu M, Sonehara K, Wada Y, Tateishi K, Hanaoka M.
Thorac Cancer, 2021 - A Case of Lung Adenocarcinoma with Long-Term Response after Late-Onset Pembrolizumab-Induced Acute Adrenal Insufficiency
Sonehara K, Tateishi K, Hirabayashi T, Araki T, Ikuyama Y, Machida R, Hanaoka M.
Case Rep Oncol, 2021 - Pembrolizumab-Induced Adrenal Insufficiency in Patients with Untreated Advanced Non-Small Cell Lung Cancer: A Case Series
Sonehara K, Tateishi K, Araki T, Komatsu M, Akahane J, Yamamoto H, Hanaoka M.
Case Rep Oncol, 2021 - Thymic epithelial tumor with superior vena cava syndrome diagnosed by percutaneous endovascular tumor biopsy: A report of two cases
Araki T, Kobayashi T, Kobayashi S, Sonehara K, Tateishi K, Kanda S, Hanaoka M, Koizumi T.
Respir Investig, 2021 - Prognostic factors for patients with metastatic or recurrent thymic carcinoma receiving palliative-intent chemotherapy
Okuma, Yusuke; Ko, Ryo; Shukuya, Takehito; Tateishi, Kazunari; Imai, Hisao; Iwasawa, Shunichiro; Miyauchi, Eisaku; Kojima, Tetsuya; Fujita, Yuka; Hino, Toshihiko; Yamanda, Shinsuke; Suzuki, Toshiro; Fukuizumi, Aya; Sakakibara, Tomohiro; Harada, Toshiyuki; Morita, Satoshi; Kobayashi, Kunihiko; Nukiwa, Toshihiro; Takahashi, Kazuhisa; North East Japan Study Grp;
Lung Cancer, 148, 122-128, Oct. 2020 - Clinical Outcomes of Second-Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study
Tateishi, Kazunari; Ko, Ryo; Shukuya, Takehito; Okuma, Yusuke; Watanabe, Satoshi; Kuyama, Shoichi; Murase, Kyoko; Tsukita, Yoko; Ashinuma, Hironori; Nakagawa, Taku; Uematsu, Kazutsugu; Nakao, Mika; Mori, Yoshiaki; Kaira, Kyoichi; Mouri, Atsuto; Miyabayashi, Takao; Sakashita, Hiroyuki; Matsumoto, Yoko; Tanigawa, Tomoyuki; Koizumi, Tomonobu; Morita, Satoshi; Kobayashi, Kunihiko; Nukiwa, Toshihiro; Takahashi, Kazuhisa; North East Japan Study Grp;
Oncologist, 25(4), E668-E678, Apr. 2020
- Successful recovery from critical COVID-19 pneumonia with extracorporeal membrane oxygenation: A case report
Ikuyama Y, Wada Y, Tateishi K, Kitaguchi Y, Yasuo M, Ushiki A, Urushihata K, Yamamoto H, Kamijo H, Mita A, Imamura H, Hanaoka M.
Respir Med Case Rep, 2020 - Phase II study of cisplatin/pemetrexed combined with bevacizumab followed by pemetrexed/bevacizumab maintenance therapy in patients with EGFR-wild advanced non-squamous non-small cell lung cancer
Fukushima, Toshirou; Wakatsuki, Yuuki; Kobayashi, Takashi; Sonehara, Kei; Tateishi, Kazunari; Yamamoto, Manabu; Masubuchi, Takeshi; Yoshiike, Fumiaki; Hirai, Kazuya; Hachiya, Tsutomu; Koizumi, Tomonobu;
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 81(6), 1043-1050, Jun. 2018 - Correlation of early PET findings with tumor response to molecular targeted agents in patients with advanced driver-mutated non-small cell lung cancer.
Koizumi T, Fukushima T, Gomi D, Kobayashi T, Sekiguchi N, Mamiya K, Tateishi K, Katou A, Oguchi K.
Med Oncol, 34(10), 169, Sep. 2017 - Two patients with TAFRO syndrome exhibiting strikingly similar anterior mediastinal lesions with predominantly fat attenuation on chest computed tomography.
Ozawa Y, Yamamoto H, Yasuo M, Takahashi H, Tateishi K, Ushiki A, Kawakami S, Fujinaga Y, Asaka S, Sano K, Takayama H, Imamura H, Hanaoka M.
Respir Investig, 55(2), 176-180, Mar. 2017 - Clinical analysis of patients treated with afatinib for advanced non-small cell lung cancer: A Nagano Lung Cancer Research Group observational study.
Wada Y, Koyama S, Kuraishi H, Miyahara T, Yoshiike F, Agatsuma T, Yamamoto R, Ono Y, Suzuki T, Hachiya T, Gomi D, Tateishi K, Hanaoka M, Koizumi T.
Respir Investig, 54(6), 462-467, Nov. 2016 - A case of pulmonary Mycobacterium avium infection in an immunocompetent patient who showed a huge consolidation with a high FDG uptake on PET/CT.
Kato A, Yamamoto H, Ikeda M, Tateishi K, Ushiki A, Yasuo M, Kawakami S, Asaka S, Oguchi K, Hanaoka M.
Respir Med Case Rep, 19, 49-52, Jul. 2016 - Development of an S-1 dosage formula based on renal function by a prospective pharmacokinetic study.
Booka E, Imamura CK, Takeuchi H, Hamamoto Y, Gomi D, Mizukami T, Ichiyama T, Tateishi K, Takahashi T, Kawakubo H, Soejima K, Boku N, Tanigawara Y, Kitagawa Y.
Gastric Cancer, 19(3), 876-86, Jul. 2016 - Nivolumab-induced organizing pneumonia in a melanoma patient
Sano, Tasuku; Uhara, Hisashi; Mikoshiba, Yasutomo; Kobayashi, Aya; Uchiyama, Ryuhei; Tateishi, Kazunari; Yamamoto, Hiroshi; Okuyama, Ryuhei;
Japanese journal of clinical oncology, 46(3), 270-272, Mar. 2016 - Clinical outcomes in patients with small cell lung cancer in a single institute: Comparative analysis of radiographic screening with symptom-prompted patients
Fukushima, Toshirou; Tateishi, Kazunari; Hanaoka, Masayuki; Koizumi, Tomonobu;
Lung Cancer, 88(1), 48-51, Apr. 2015 - Development of dosing recommendation of S-1 for patients with impaired renal function by prospective pharmacokinetic study.
Booka, Eisuke; Imamura, Chiyo K.; Hamamoto, Yasuo; Mizukami, Takuro; Gomi, Daisuke; Ichiyama, Takashi; Tateishi, Kazunari; Takahashi, Tsunehiro; Kawakubo, Hirofumi; Soejima, Kenzo; Takeuchi, Hiroya; Boku, Narikazu; Tanigawara, Yusuke; Kitagawa, Yuko;
JOURNAL OF CLINICAL ONCOLOGY, 33(15), 2015 - Hypertrophic Pulmonary Osteoarthropathy in Anaplastic Lymphoma Kinase (ALK)-positive Lung Cancer
Komatsu, Masamichi; Yasuo, Masanori; Kobayashi, Nobumitsu; Tateishi, Kazunari; Ushiki, Atsuhito; Urushihata, Kazuhisa; Yamamoto, Hiroshi; Hanaoka, Masayuki; Matoba, Hisanori; Honda, Takayuki; Ichikawa, Kosuke;
INTERNAL MEDICINE, 54(16), 2045-2049, 2015 - Hypertrophic Pulmonary Osteoarthropathy in Anaplastic Lymphoma Kinase (ALK)-positive Lung Cancer
Komatsu, Masamichi; Yasuo, Masanori; Kobayashi, Nobumitsu; Tateishi, Kazunari; Ushiki, Atsuhito; Urushihata, Kazuhisa; Yamamoto, Hiroshi; Hanaoka, Masayuki; Matoba, Hisanori; Honda, Takayuki; Ichikawa, Kosuke;
INTERNAL MEDICINE, 54(16), 2045-2049, 2015 - Late-onset Rejection of a Unilateral Donor Lung with Vascular C4d Deposition in Bilateral Living-donor Lobar Lung Transplantation: An Autopsy Case Report
Yamamoto, Hiroshi; Yoshida, Kazuo; Koizumi, Tomonobu; Tokoro, Yayoi; Fukushima, Toshiro; Tateishi, Kazunari; Ushiki, Atsuhito; Yokoyama, Toshiki; Yasuo, Masanori; Urushihata, Kazuhisa; Hanaoka, Masayuki; Shingu, Kunihiko; Shimojo, Hisashi; Kanno, Hiroyuki; Yoshizawa, Akihiko; Kawakami, Satoshi; Miyagawa-Hayashino, Aya; Date, Hiroshi; Kubo, Keishi;
INTERNAL MEDICINE, 53(15), 1645-1650, 2014 - A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING IN LUNG CANCER PATIENTS
Fujita, Masaki; Takayama, Koichi; Ono, Akira; Takeda, Koji; Ohira, Tatsuo; Isobe, Hiroshi; Ebi, Noriyuki; Tateishi, Kazunari; Yamamoto, Nobuyuki; Nakanishi, Yoichi; Tamura, Kazuo;
JOURNAL OF THORACIC ONCOLOGY, 8, S406-S406, Nov. 2013 - Clinical characteristics and outcomes of patients with small cell lung cancer detected by CT screening
Fukushima, T; Tateishi, K; Yamamoto, H; Hanaoka, M; Kubo, K; Koizumi, T
MEDICAL ONCOLOGY, 30(3), 623, Sep. 2013 - Clinical outcomes in elderly patients administered gefitinib as first-line treatment in epidermal growth factor receptor-mutated non-small-cell lung cancer: retrospective analysis in a Nagano Lung Cancer Research Group Study
Tateishi K, Ichiyama T, Hirai K, Agatsuma T, Koyama S, Hachiya T, Morozumi N, Shiina T, Koizumi T.
MEDICAL ONCOLOGY, 30, 450, 13 Jan. 2013 - Primary malignant sarcomatoid mesothelioma in the pericardium
Tateishi Kazunari,Ikeda Mariko,Yokoyama Toshiki,Urushihata Kazuhisa,Yamamoto Hiroshi,Hanaoka Masayuki,Kubo Keishi,Sakai Yasuhiro,Nakayama Jun,Koizumi Tomonobu
INTERNAL MEDICINE, 52(2), 249-253, 2013 - 呼吸器診療での肺機能検査の必要性とその活用(11)疾患編 肺血管障害
立石 一成,花岡 正幸,久保 惠嗣
呼吸と循環, 60(11), 1144-1148, Nov. 2012 - CLINICAL UTILITY OF CT-GUIDED BRONCHOSCOPY RADIOFREQUENCY ABLATION AS A NOVEL INTERVENTION THERAPY FOR LUNG CANCER
Koizumi, Tomonobu; Tanabe, Tuyoshi; Tsushima, Kenji; Tateishi, Kazunari; Fukushima, Toshiro; Hama, M.; Horiuchi, M.; Kobayashi, N.; Ikegami, K.; Tokoro, Y.; Ushiki, A.; Yokoyama, T.; Kobayashi, T.; Yasuo, M.; Urushihata, K.; Yamamoto, H.; Hanaoka, M.; Kubo, K.;
JOURNAL OF THORACIC ONCOLOGY, 7(11), S447-S447, Nov. 2012 - 診断および治療経過を観察できた肺腺癌小腸転移の1例
立石 一成,小泉 知展,漆畑 一寿,山本 洋,花岡 正幸,久保 惠嗣
肺癌, 52(3), 310-314, 2012
Lectures, oral presentations, etc.
- MS66. PD-L1高発現非小細胞肺癌患者におけるペムブロリズマブおよびプラチナ製剤併用療法 + ペムブロリズマブの多施設共同観察研究 (第2報)PP364. 進行非小細胞肺癌における免疫チェックポイント阻害薬の長期奏効に関わる臨床的検討PP482. 気管支鏡検体におけるOncomine(TM) Dx Target Testによる解析の後方視的検討PP651. 進行非小細胞肺癌における複合免疫療法の臨床的有用性を評価した多施設共同後方視的研究P8-4. PS2の進行・再発非小細胞肺癌における複合免疫療法の実際P10-5. 75歳以上未治療進行・再発非小細胞肺癌における複合免疫療法の有効性・安全性の検討P52-2. 初回オシメルチニブ耐性後のEGFR TKI再投与に関する臨床的検討MS55. 進行非小細胞肺癌におけるPD-1阻害剤の早期効果予測としてのFDG-PETMS102. PD-L1高発現NSCLC患者におけるペムブロリズマブおよびプラチナ製剤併用療法+ペムブロリズマブの多施設共同観察研究PP299. 複合免疫療法を受けた進行非小細胞肺癌患者における脊柱起立筋面積と予後との関連PP557. 免疫療法を施行された非小細胞肺癌症例の免疫関連有害事象の発症予測因子としてのLung immune prognostic indexの有用性PP565. 免疫関連有害事象としての副腎機能不全の臨床的特徴に関する後方視的検討O26-2. 進行非小細胞肺癌におけるPD-1阻害剤の早期効果予測としてのFDG-PET4. ALK陽性肺紡錘細胞癌の1例PD11-1-2. 進行・再発非小細胞肺癌の1次治療における免疫チェックポイント阻害薬の長期奏効に関わる臨床的背景の検討OP528. 免疫療法が施行された非小細胞肺癌症例の予後および治療効果予測における免疫関連有害事象の役割に関する後方視的な検討
